We provide you with 20 years of free, institutional-grade data for ABT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ABT. Explore the full financial landscape of ABT stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Cushman Elizabeth C. | Initial | 2025-07-01 | |||
| Shroff Eric | Initial | 2025-03-03 | |||
| MCCOY JOHN A. JR. | Initial | 2023-09-06 |
The information provided in this report about ABT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Abbott Laboratories(NYSE:ABT) 
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmac...
Website: http://www.abbott.com
Founded: 1888
Full Time Employees: 107,000
CEO: Robert Ford
Sector: Healthcare
Industry: Medical Devices
